Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""ctDNA"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 438
Tytuł:
Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic Review.
Autorzy:
Temperley HC; Department of Radiology, St. James's Hospital, D08 NHY1 Dublin, Ireland.; Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.; Trinity St. James's Cancer Institute, D08 NHY1 Dublin, Ireland.
Fannon T; Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
O'Sullivan NJ; Department of Radiology, St. James's Hospital, D08 NHY1 Dublin, Ireland.
O'Neill M; Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
Mac Curtain BM; Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
Gilham C; Department of Radiation Oncology, St. James's Hospital, D08 NHY1 Dublin, Ireland.
O'Sullivan J; Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute, Trinity College, St. James's Hospital, D08 NHY1 Dublin, Ireland.
O'Kane G; Department of Medical Oncology, St. James's Hospital, D08 NHY1 Dublin, Ireland.
Mehigan BJ; Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
O'Toole S; Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute, Trinity College, St. James's Hospital, D08 NHY1 Dublin, Ireland.
Larkin JO; Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
Gallagher D; Department of Medical Oncology, St. James's Hospital, D08 NHY1 Dublin, Ireland.; Department of Genetics, St. James's Hospital, D08 NHY1 Dublin, Ireland.
McCormick P; Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
Kelly ME; Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.; Trinity St. James's Cancer Institute, D08 NHY1 Dublin, Ireland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 03; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Circulating Tumor DNA*/genetics
Anus Neoplasms*/diagnosis
Anus Neoplasms*/genetics
Anus Neoplasms*/therapy
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/therapy
Humans ; Biomarkers
SCR Disease Name:
Anal Canal Carcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.
Autorzy:
Huang L; Medical Center on Aging of Ruijin Hospital, MCARJH, Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China. .; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Lv Y; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Guan S; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Yan H; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Han L; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Wang Z; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. .
Han Q; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. .
Dai G; Department of Medical Oncology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. .
Shi Y; Department of General Surgery, Shanghai Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, 358 Datong Road, Gaoqiao Town, Shanghai, 200137, China. sy_.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 20; Vol. 22 (1), pp. 184. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/pathology
Adenocarcinoma*/genetics
Albumins*
Paclitaxel*
Humans ; Prospective Studies ; Prognosis ; CA-19-9 Antigen ; Proto-Oncogene Proteins p21(ras)/genetics ; Mutation/genetics ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
Autorzy:
Zhang Y; Department of Infectious diseases, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Du H; Department of Emergency, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Wang N; Department of Molecular Biology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Wang L; Department of Thoracic Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Huang Y; Department of Medical oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 24; Vol. 24 (1), pp. 129. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/therapy
Humans ; Databases, Factual ; Gene Library ; Genes, cdc
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
ACEK Biosensor for the Minute-Scale Quantification of Breast Cancer ctDNA.
Autorzy:
Wang K; Key Laboratory of Optoelectronic Technology and Systems of Ministry of Education of China, Chongqing University, Chongqing 400044, China.
Lin X; Key Laboratory of Optoelectronic Technology and Systems of Ministry of Education of China, Chongqing University, Chongqing 400044, China.
Zhang M; Key Laboratory of Optoelectronic Technology and Systems of Ministry of Education of China, Chongqing University, Chongqing 400044, China.
Yang M; Key Laboratory of Optoelectronic Technology and Systems of Ministry of Education of China, Chongqing University, Chongqing 400044, China.
Shi X; Key Laboratory of Optoelectronic Technology and Systems of Ministry of Education of China, Chongqing University, Chongqing 400044, China.
Xie M; Key Laboratory of Optoelectronic Technology and Systems of Ministry of Education of China, Chongqing University, Chongqing 400044, China.
Luo Y; Center of Smart Laboratory and Molecular Medicine, NHC Key Laboratory of Birth Defects and Reproductive Health, School of Medicine, Chongqing University, Chongqing 400044, China.
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2024 Jan 15; Vol. 24 (2). Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Journal Article
MeSH Terms:
Biosensing Techniques*
Cheilitis*
Circulating Tumor DNA*
Neoplasms*
Humans ; Amides
SCR Disease Name:
Actinic cheilitis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
Autorzy:
Roussel-Simonin C; Drug Development Department (DITEP), Gustave-Roussy Cancer Campus, Villejuif. Sorbonne Université, Paris, France. .
Blanc-Durand F; Departement of Medecine, Gustave-Roussy Cancer Campus, INSERM U981, Université Paris-Saclay, Villejuif, France.; Université Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France.
Tang R; Cancer Genetics Laboratory, Medical Biology and Pathology Department, Gustave-Roussy Cancer Campus, Villejuif, France.
Vasseur D; Cancer Genetics Laboratory, Medical Biology and Pathology Department, Gustave-Roussy Cancer Campus, Villejuif, France.
Le Formal A; Université Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France.
Chardin L; Université Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France.
Yaniz E; Université Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France.
Gouy S; Department of Pathology and Medical Biology, Gustave-Roussy Cancer Campus, Villejuif, France.
Maulard A; Department of Pathology and Medical Biology, Gustave-Roussy Cancer Campus, Villejuif, France.
Scherier S; Department of Pathology and Medical Biology, Gustave-Roussy Cancer Campus, Villejuif, France.
Sanson C; Department of Pathology and Medical Biology, Gustave-Roussy Cancer Campus, Villejuif, France.
Lacroix L; Department of Gynecologic Surgery, Gustave-Roussy Cancer Campus, Villejuif, France.
Cotteret S; Cancer Genetics Laboratory, Medical Biology and Pathology Department, Gustave-Roussy Cancer Campus, Villejuif, France.
Mauny L; Department of Pathology and Medical Biology, Gustave-Roussy Cancer Campus, Villejuif, France.
Zaccarini F; Department of Pathology and Medical Biology, Gustave-Roussy Cancer Campus, Villejuif, France.
Rouleau E; Université Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France.; Cancer Genetics Laboratory, Medical Biology and Pathology Department, Gustave-Roussy Cancer Campus, Villejuif, France.
Leary A; Departement of Medecine, Gustave-Roussy Cancer Campus, INSERM U981, Université Paris-Saclay, Villejuif, France.; Université Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France.
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2023 Nov 06; Vol. 22 (1), pp. 178. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/genetics
Circulating Tumor DNA*
Female ; Humans ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Mutation ; Homologous Recombination ; Ascitic Fluid/pathology ; Ascites ; Prospective Studies ; Retrospective Studies ; Carcinoma, Ovarian Epithelial ; Genomic Instability
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
Autorzy:
Bayle A; DITEP, Gustave Roussy, Villejuif, France.
Belcaid L; DITEP, Gustave Roussy, Villejuif, France.; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Palmieri LJ; Department of Medicine, Institut Bergonié, Bordeaux, France.
Teysonneau D; Department of Medicine, Institut Bergonié, Bordeaux, France.
Cousin S; Department of Medicine, Institut Bergonié, Bordeaux, France.
Spalato-Ceruso M; Department of Medicine, Institut Bergonié, Bordeaux, France.
Aldea M; Department of Medicine, Gustave Roussy, Villejuif, France.
Vasseur D; Department of Biopathology, Gustave Roussy, Villejuif, France.
Alame M; Department of Biopathology, Institut Bergonié, Bordeaux, France.
Blouin L; Department of Biopathology, Institut Bergonié, Bordeaux, France.
Soubeyran I; Department of Biopathology, Institut Bergonié, Bordeaux, France.
Nicotra C; DITEP, Gustave Roussy, Villejuif, France.
Ngocamus M; DITEP, Gustave Roussy, Villejuif, France.
Hollebecque A; DITEP, Gustave Roussy, Villejuif, France.
Loriot Y; DITEP, Gustave Roussy, Villejuif, France.
Besse B; Department of Medicine, Gustave Roussy, Villejuif, France.; Faculty of Medicine, Paris Saclay University, Kremlin-Bicêtre, France.
Lacroix L; Department of Biopathology, Gustave Roussy, Villejuif, France.
Rouleau E; Department of Biopathology, Gustave Roussy, Villejuif, France.
Barlesi F; DITEP, Gustave Roussy, Villejuif, France.; Faculty of Medicine, Paris Saclay University, Kremlin-Bicêtre, France.
Andre F; Department of Medicine, Institut Bergonié, Bordeaux, France.; Faculty of Medicine, Paris Saclay University, Kremlin-Bicêtre, France.
Italiano A; DITEP, Gustave Roussy, Villejuif, France. .; Department of Medicine, Institut Bergonié, Bordeaux, France. .; Faculty of Medicine, University of Bordeaux, Bordeaux, France. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2023 Nov 04; Vol. 22 (1), pp. 176. Date of Electronic Publication: 2023 Nov 04.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Circulating Tumor DNA*/genetics
Neoplasms*/drug therapy
Neoplasms*/genetics
Humans ; Precision Medicine ; Prognosis ; Prospective Studies ; Biomarkers, Tumor/genetics ; Mutation ; High-Throughput Nucleotide Sequencing
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing.
Autorzy:
Fernandez SV; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Tan YF; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Rao S; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Fittipaldi P; Protocol Support Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Sheriff F; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Borghaei H; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Dotan E; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Winn JS; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Edelman MJ; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Treat J; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Judd J; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Alpaugh RK; Protocol Support Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Wang YL; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Yu JQ; Department of Radiology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Wasik M; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Baldwin DA; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 30; Vol. 24 (21). Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Neoplasms*/diagnosis
Neoplasms*/genetics
Humans ; Pathology, Molecular ; INDEL Mutation ; Molecular Diagnostic Techniques ; High-Throughput Nucleotide Sequencing/methods ; Mutation ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
Autorzy:
Wullaert L; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
van Rees JM; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Grünhagen DJ; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Verhoef C; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Oct 25; Vol. 12 (21). Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Circulating Tumor DNA*/genetics
Liver Neoplasms*/genetics
Colorectal Neoplasms*/genetics
Humans ; Biomarkers ; Combined Modality Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay.
Autorzy:
Koukourakis MI; Department of Radiotherapy-Oncology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Xanthopoulou E; Department of Radiotherapy-Oncology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Koukourakis IM; Radiation Oncology Unit, 1st Department of Radiology, Aretaieion University Hospital, 11528 Athens, Greece.
Fortis SP; Cancer Immunology and Immunotherapy Center, Cancer Research Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Kesesidis N; Laboratory of Biology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Kakouratos C; Department of Radiotherapy-Oncology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Karakasiliotis I; Laboratory of Biology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Baxevanis CN; Cancer Immunology and Immunotherapy Center, Cancer Research Center, Saint Savas Cancer Hospital, 11522 Athens, Greece.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Sep 29; Vol. 30 (10), pp. 8902-8915. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Circulating Tumor DNA*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Neoplasm Recurrence, Local/genetics ; Mutation ; High-Throughput Nucleotide Sequencing ; Chemoradiotherapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Autorzy:
Kresse SH; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
Brandt-Winge S; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
Pharo H; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
Flatin BTB; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
Jeanmougin M; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
Vedeld HM; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway.
Lind GE; Department of Molecular Oncology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379, Oslo, Norway. .; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2023 Sep 14; Vol. 15 (1), pp. 151. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Circulating Tumor DNA*/genetics
Cell-Free Nucleic Acids*
Neoplasms*
Humans ; DNA Methylation ; Transaminases ; Transcription Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer.
Autorzy:
Olivier T; Department of Oncology, Geneva University Hospital, 4 Gabrielle-Perret-Gentil Street, 1205, Geneva, Switzerland. .
Haslam A; Department of Epidemiology and Biostatistics, University of California San Francisco, 550 16th St, 2nd Fl, San Francisco, CA, 94158, USA.
Prasad V; Department of Epidemiology and Biostatistics, University of California San Francisco, 550 16th St, 2nd Fl, San Francisco, CA, 94158, USA.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Sep 08; Vol. 21 (1), pp. 344. Date of Electronic Publication: 2023 Sep 08.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Circulating Tumor DNA*/genetics
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Humans ; Chemotherapy, Adjuvant ; Adjuvants, Immunologic ; Oxaliplatin
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV-associated cancers; a meta-analysis on recurrent event endpoints.
Autorzy:
Karimi A; Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Jafari-Koshki T; Department of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
Zehtabi M; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Kargar F; Department of Medical Biotechnology, Faculty of Medical School, Tabriz University of Medical Sciences, Tabriz, Iran.
Gheit T; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC), Lyon, France.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 17592-17602. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Papillomavirus Infections*/complications
Papillomavirus Infections*/diagnosis
Circulating Tumor DNA*
Head and Neck Neoplasms*
Humans ; Human Papillomavirus Viruses ; Neoplasm Recurrence, Local
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation.
Autorzy:
Dao J; Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Conway PJ; Mays Cancer Center, University of Texas Health, San Antonio, TX 78229, USA.; Graduate School of Biomedical Sciences, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Subramani B; Mays Cancer Center, University of Texas Health, San Antonio, TX 78229, USA.; Graduate School of Biomedical Sciences, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Meyyappan D; Mays Cancer Center, University of Texas Health, San Antonio, TX 78229, USA.
Russell S; Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Mahadevan D; Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USA.; Mays Cancer Center, University of Texas Health, San Antonio, TX 78229, USA.; Graduate School of Biomedical Sciences, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 25; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cell-Free Nucleic Acids*/genetics
Circulating Tumor DNA*
Liquid Biopsy ; Biopsy ; Gene Frequency
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling.
Autorzy:
Grolleau E; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Pulmonology Department, Lyon Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.
Candiracci J; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium.
Lescuyer G; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Barthelemy D; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Benzerdjeb N; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Pathology Department, Claude Bernard University Lyon I, Hospices Civils de Lyon, 69677 Bron, France.
Haon C; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Geiguer F; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Raffin M; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Hardat N; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium.
Balandier J; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Rabeuf R; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium.
Chalabreysse L; Pathology Department, Claude Bernard University Lyon I, Hospices Civils de Lyon, 69677 Bron, France.
Wozny AS; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.; Cellular and Molecular Radiobiology Laboratory UMR CNRS5822/IP2I, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.
Rommelaere G; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium.
Rodriguez-Lafrasse C; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.; Cellular and Molecular Radiobiology Laboratory UMR CNRS5822/IP2I, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.
Subtil F; Statistic Department, Hospices Civils de Lyon, 69008 Lyon, France.; LBBE, Claude Bernard University Lyon I, UMR 5558, CNRS, 69100 Villeurbanne, France.
Couraud S; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Pulmonology Department, Lyon Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.
Herzog M; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium.
Payen-Gay L; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 Aug 16; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Circulating Tumor DNA*/genetics
Cell-Free Nucleic Acids*
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Humans ; Nucleosomes/genetics ; Histones/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Network approach in liquidomics landscape.
Autorzy:
Santini D; Oncologia Medica A, Policlinico Umberto 1, La Sapienza Università Di Roma, Rome, Italy.
Botticelli A; Oncologia Medica A, Policlinico Umberto 1, La Sapienza Università Di Roma, Rome, Italy.
Galvano A; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
Iuliani M; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Department of Medicine and Surgery, Università Campus Bio-Medico Di Roma, Selcetta, Italy.
Incorvaia L; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
Gristina V; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
Taffon C; Anatomical Pathology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Medicine and Surgery, Research Unit of Anatomical Pathology, Università Campus Bio-Medico Di Roma, Rome, Italy.
Foderaro S; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Department of Medicine and Surgery, Università Campus Bio-Medico Di Roma, Selcetta, Italy.
Paccagnella E; Department of Medical Surgical Sciences and Biotechnologies, Sapienza University of Rome, C.So Della Repubblica 79, 04100, Latina, Italy.
Simonetti S; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Department of Medicine and Surgery, Università Campus Bio-Medico Di Roma, Selcetta, Italy.
Fazio F; UOC Oncologia Territoriale, Polo Pontino, La Sapienza Università Di Roma, Latina, Italy. Federico_.
Scagnoli S; Oncologia Medica A, Policlinico Umberto 1, La Sapienza Università Di Roma, Rome, Italy.
Pomati G; INI Casa Di Cura, Grottaferrata, Italy.
Pantano F; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Department of Medicine and Surgery, Università Campus Bio-Medico Di Roma, Selcetta, Italy.
Perrone G; Anatomical Pathology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Medicine and Surgery, Research Unit of Anatomical Pathology, Università Campus Bio-Medico Di Roma, Rome, Italy.
De Falco E; Department of Medical Surgical Sciences and Biotechnologies, Sapienza University of Rome, C.So Della Repubblica 79, 04100, Latina, Italy.; Mediterranea Cardiocentro, 80122, Naples, Italy.
Russo A; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
Spinelli GP; UOC Oncologia Territoriale, Polo Pontino, La Sapienza Università Di Roma, Latina, Italy.
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Aug 04; Vol. 42 (1), pp. 193. Date of Electronic Publication: 2023 Aug 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
Circulating Tumor DNA*/genetics
Humans ; Biomarkers, Tumor/genetics ; Liquid Biopsy/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer.
Autorzy:
Chen K; Thoracic Oncology Institute and Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China. .; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, 72 Huntley St, London, WC1E 6DD, UK. .
Kang G; Thoracic Oncology Institute and Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China.
Zhang Z; Burning Rock Biotech, Guangzhou, 510300, China.
Lizaso A; Burning Rock Biotech, Guangzhou, 510300, China.
Beck S; University College London Cancer Institute, University College London, 72 Huntley St, London, WC1E 6DD, UK.
Lyskjær I; University College London Cancer Institute, University College London, 72 Huntley St, London, WC1E 6DD, UK.
Chervova O; University College London Cancer Institute, University College London, 72 Huntley St, London, WC1E 6DD, UK.
Li B; Burning Rock Biotech, Guangzhou, 510300, China.
Shen H; Thoracic Oncology Institute and Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China.
Wang C; Burning Rock Biotech, Guangzhou, 510300, China.
Li B; Burning Rock Biotech, Guangzhou, 510300, China.
Zhao H; Thoracic Oncology Institute and Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China.
Li X; Burning Rock Biotech, Guangzhou, 510300, China.
Yang F; Thoracic Oncology Institute and Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China. .
Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, 72 Huntley St, London, WC1E 6DD, UK. .
Wang J; Thoracic Oncology Institute and Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Jul 14; Vol. 21 (1), pp. 255. Date of Electronic Publication: 2023 Jul 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell-Free Nucleic Acids*/genetics
Circulating Tumor DNA*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Humans ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; DNA Methylation/genetics ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer.
Autorzy:
Lee DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Lim Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kim HP; IMBdx, Inc., Seoul, Korea.
Kim SY; IMBdx, Inc., Seoul, Korea.
Roh H; IMBdx, Inc., Seoul, Korea.
Kang JK; IMBdx, Inc., Seoul, Korea.
Lee KH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Kim MJ; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
Ryoo SB; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
Park JW; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
Jeong SY; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
Park KJ; Department of Surgery, Seoul National University Hospital, Seoul, Korea.
Kang GH; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Han SW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; IMBdx, Inc., Seoul, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Jul; Vol. 55 (3), pp. 927-938. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Colonic Neoplasms*/pathology
Cell-Free Nucleic Acids*
Rectal Neoplasms*
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Humans ; Protein-Tyrosine Kinases/genetics ; Proto-Oncogene Proteins/genetics ; Treatment Outcome ; Biomarkers, Tumor/genetics ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.
Autorzy:
Ma X; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Zhang K; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Xu J; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Gao H; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Yang S; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Qin H; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Wang H; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Gao F; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Liu X; Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Jul; Vol. 14 (20), pp. 1980-1990. Date of Electronic Publication: 2023 Jun 02.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Circulating Tumor DNA*/genetics
Humans ; Anaplastic Lymphoma Kinase/genetics ; Drug Resistance, Neoplasm/genetics ; Lactams, Macrocyclic/adverse effects ; Protein Kinase Inhibitors/pharmacology ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 438

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies